| 英文别名 |
CPI-1205;CPI1205;CPI 1205;455J2479FY;(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide;N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]indole-3-carboxamide;Lirametostat;GTPL9115;AMY16797;BCP19174;NSC793430;s8353;DB1;N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-((1R)-1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide;BDBM50541920;compound 13 [PMID: 27739677];WPC86270;N-((4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl)-2-methyl-1-((1R)-1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)indole-3-carboxamide;1H-Indole-3-carboxamide, N-((1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl)-2-methyl-1-((1R)-1-(1-(2,2,2-trifluoroethyl)-4-piperidinyl)ethyl)-;1621862-70-1;TS-09815;SCHEMBL17329268;GLXC-10078;DA-52117;DB14581;SB19773;LIRAMETOSTAT [WHO-DD];LIRAMETOSTAT [INN];UNII-455J2479FY;1H-Indole-3-carboxamide, N-[(1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)-4-piperidinyl]ethyl]-;EX-A1068;CCG-269843;compound 13 (PMID: 27739677);CHEMBL4297463;HY-100021;N-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]-1H-indole-3-carboxamide;AKOS030628484;NSC-793430;AC-35895;Ezh2 inhibitor cpi-1205;CS-7648;HPODOLXTMDHLLC-QGZVFWFLSA-N |
微信公众号
客服
